WinstonWınston
Back
Sintx Technologies logo

Sintx Technologies

SINT
31
Medical - Devices · Healthcare
Exchange
NASDAQ Capital Market
Winston Score
31
Winston is serious
Below-average fundamentals — multiple weak pillars.
Data as of Aug 23, 2026 · filings through Jun 30, 2026
How the score breaks down
Quality
Mixed
Growth
Good
Cash Flow
Weak
Stability
Data not available
Valuation
Data not available

Winston Score History

The full picture

Sintx Technologies is a small medical materials company that makes products using silicon nitride, a tough ceramic material originally developed for industrial uses. The company focuses on using silicon nitride in medical implants, particularly spinal fusion devices, and is researching its use in antibacterial and antiviral applications. It sells to hospitals and surgical centers, primarily in the United States.

Sintx makes money by selling its silicon nitride-based medical devices and through research partnerships and licensing agreements. The company is very small, with a market cap near zero and deeply negative profit margins, meaning it spends far more than it earns. Its main competitive angle is its specialized knowledge of silicon nitride ceramics, which few other companies work with in medical settings. The biggest risk the company faces is running out of cash before it can grow its product sales enough to become profitable, which is a serious concern given its current financial losses.

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

+352.0% YoY

YoY Growth Rate

Revenue accelerating

EPS Growth

+17.6% YoY

YoY Growth Rate

Steady EPS growth

Insider Activity

16.5%ownership

Insiders own a meaningful stake in the company

Cash Runway

~4 months

$4M cash & investments

Quarterly Free Cash Flow

→ Burn rate stable

Short runway — potential dilution ahead through share issuance

Revenue accelerating

Sintx Technologies grew revenue 352% year-over-year and the growth rate is speeding up. That's the kind of momentum growth investors look for — the question is whether margins can follow.

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Profit per sale
Gross Margin
61.5%
Premium pricing power — 61.5% gross margin
Profit after running costs
Operating Margin
-638.9%
Losing money on operations — -638.9%
Return on the money invested
ROCE
-243.6%
Weak — -243.6% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales growth
Sales YoY
+0.2%
Nearly flat sales (+0.2% YoY)
Profit growth
EPS YoY
N/A
Data not available
How steady the profit is
EPS Consistency
8/8 quarters
Every recent quarter grew earnings vs last year

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Profit that turns into cash
Cash Conversion
N/A
Data not available
Spare cash per sale
FCF Margin
-748.4%
Burning cash (-748.4%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

What it owes vs what it owns
Debt / Equity
N/A
Data not available
Covers its interest
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

Price vs profit
P/E Ratio (TTM)
N/M
no trend
Negative earnings — P/E not meaningful
Cheaper or dearer next year
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial